Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record.

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

Open access
Hofmann, Guenter, Bauernhofer, Thomas, Krippl, Peter, Lang-Loidolt, Doris, Horn, Sabine, Goessler, Walter, Schippinger, Walter, Ploner, Ferdinand, Stoeger, Herbert, Samonigg, Hellmut · 2006 · BMC Cancer

Abstract

Background: Cisplatin is widely used as an antineoplastic agent since it is effective against a broad spectrum of different tumours. Nevertheless, it has several potential side effects affecting different organ systems and an overdose may lead to life-threatening complications and even death. Case presentation: We report on a 46-year old woman with non-small cell lung cancer who accidentally received 225 mg/m 2 of cisplatin, which was threefold the dose as scheduled, within a 3-day period. Two days later, the patient presented with hearing loss, severe nausea and vomiting, acute renal failure as well as elevated liver enzymes. In addition, she developed a severe myelodepression. After plasmapheresis on two consecutive days and vigorous supportive treatment, the toxicity-related symptoms improved and the patient recovered without any sequelae. Conclusion: To date, no general accepted guidelines for the treatment of cisplatin overdoses are available. Along with the experience from other published cases, our report shows that plasmapheresis is capable of lowering cisplatin plasma and serum levels efficiently. Therefore, plasma exchange performed as soon as possible can ameliorate all side effects of a cisplatin overdose and be a potential tool for clinicians for treatment. However, additional intensive supportive treatment-modalities are necessary to control all occurring side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-6-1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 25

  1. Markman M: Toxicities of the platinum antineoplastic agents. Expert Opin Drug Saf. 2003, 2 (6): 597-607. 10.1517/14740338.2.6.597. · DOI
  2. Hartmann JT, Lipp HP: Toxicity of platinum compounds. Expert Opin Pharmacother. 2003, 4 (6): 889-901. 10.1517/14656566.4.6.889. · DOI · Paper page
  3. Pike IM, Arbus MH: Cisplatin overdosage. J Clin Oncol. 1992, 10 (9): 1503-1504. · doi:10.1200/jco.1992.10.9.1503
  4. Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT, Neuwelt EA: Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope. 2002, 112 (11): 1997-2001. 10.1097/00005537-200211000-00016. · DOI
  5. Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM: Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 1997, 3 (6): 331-340.
  6. Lagrange JL, Cassuto-Viguier E, Barbe V, Fischel JL, Mondain JR, Etienne MC, Ferrero JM, Creisson-Ducray A, Formento P, Milano G: Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing them. Eur J Cancer. 1994, 30A (14): 2057-2060. 10.1016/0959-8049(94)00332-Y. · doi:10.1016/0959-8049(94)00332-y
  7. Brivet F, Pavlovitch JM, Gouyette A, Cerrina ML, Tchernia G, Dormont J: Inefficiency of early prophylactic hemodialysis in cis-platinum overdose. Cancer Chemother Pharmacol. 1986, 18 (2): 183-184. 10.1007/BF00262294. · doi:10.1007/bf00262294
  8. Chu G, Mantin R, Shen YM, Baskett G, Sussman H: Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer. 1993, 72 (12): 3707-3714. · doi:10.1002/1097-0142(19931215)72:12<3707::aid-cncr2820721224>3.0.co;2-u
  9. Charlier C, Kintz P, Dubois N, Plomteux G: Fatal overdosage with cisplatin. J Anal Toxicol. 2004, 28 (2): 138-140. · doi:10.1093/jat/28.2.138
  10. Sheikh-Hamad D, Timmins K, Jalali Z: Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol. 1997, 8 (10): 1640-1644. · doi:10.1681/asn.v8101640
  11. Wu YJ, Muldoon LL, Neuwelt EA: The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther. 2005, 312 (2): 424-431. 10.1124/jpet.104.075119. · DOI · Paper page
  12. Erdlenbruch B, Pekrun A, Schiffmann H, Witt O, Lakomek M: Topical topic: accidental cisplatin overdose in a child: reversal of acute renal failure with sodium thiosulfate. Med Pediatr Oncol. 2002, 38 (5): 349-352. 10.1002/mpo.1343. · doi:10.1002/mpo.1343
  13. Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G: High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics. Laryngoscope. 2004, 114 (9): 1660-1667. 10.1097/00005537-200409000-00030. · DOI
  14. Sastry J, Kellie SJ: Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose Cisplatin and amifostine. Pediatr Hematol Oncol. 2005, 22 (5): 441-445. 10.1080/08880010590964381. · DOI · Paper page
  15. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm. 2002, 59 (17): 1648-1668. · doi:10.1093/ajhp/59.17.1648
  16. Criteria for facilities and personnel for the administration of parenteral systemic antineoplastic therapy. Adopted on March 3, 2004 by the American Society of Clinical Oncology. J Clin Oncol. 2004, 22 (22): 4613-4615. 10.1200/JCO.2004.05.077. · doi:10.1200/jco.2004.05.077
  17. Womer RB, Tracy E, Soo-Hoo W, Bickert B, DiTaranto S, Barnsteiner JH: Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. J Clin Oncol. 2002, 20 (24): 4705-4712. 10.1200/JCO.2002.04.108. · DOI
  18. Pourrat X, Antier D, Crenn I, Calais G, Jonville-Bera AP, Rouleau A: A prescription and administration error of cisplatin: a case report. Pharm World Sci. 2004, 26 (2): 64-65. 10.1023/B:PHAR.0000018602.02535.70. · DOI
  19. Choi JH, Oh JC, Kim KH, Chong SY, Kang MS, Oh do Y: Successful treatment of cisplatin overdose with plasma exchange. Yonsei Med J. 2002, 43 (1): 128-132. · doi:10.3349/ymj.2002.43.1.128
  20. Jung HK, Lee J, Lee SN: A case of massive cisplatin overdose managed by plasmapheresis. Korean J Intern Med. 1995, 10 (2): 150-154. · doi:10.3904/kjim.1995.10.2.150
  21. Linenberger ML, Price TH: Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations. J Intensive Care Med. 2005, 20 (1): 18-27. 10.1177/0885066604271394. · doi:10.1177/0885066604271394
  22. Linenberger ML, Price TH: Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications. J Intensive Care Med. 2005, 20 (2): 88-103. 10.1177/0885066604273479. · DOI
  23. Stegmayr B, Wikdahl AM: Access in therapeutic apheresis. Ther Apher Dial. 2003, 7 (2): 209-214. 10.1046/j.1526-0968.2003.00035.x. · doi:10.1046/j.1526-0968.2003.00035.x
  24. Mallat SG, Ismail N: Plasmapheresis and related techniques: what should we know. J Med Liban. 2002, 50 (1-2): 45-49.
  25. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004, 141 (12): 929-937. · DOI · Paper page

Cited by

See all 182

Metadata

Authors
Hofmann, G., Bauernhofer, T., Krippl, P., Lang-Loidolt, D., Horn, S., Goessler, W., Schippinger, W., Ploner, F., Stoeger, H., & Samonigg, H.
Venue
BMC Cancer
Published
2006-01-04
Volume
6
Issue
1
Pages
1-1
ISSN
1471-2407 (ISSN-L)
OpenAlex
W1874184388
Cited by
182
References
0
FWCI
5.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation. https://app.cochat.ai/papers/10.1186/1471-2407-6-1
The paper
Hofmann, G., Bauernhofer, T., Krippl, P., Lang-Loidolt, D., Horn, S., Goessler, W., Schippinger, W., Ploner, F., Stoeger, H., & Samonigg, H. (2006). Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation. BMC Cancer. https://doi.org/10.1186/1471-2407-6-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.